Pharmaceutical companies suspected of illegally producing drugs and selling corporate legal persons were sentenced to 10 years of expulsion from the industry

From November 2016 to March 2019, the drug company was suspected of illegally producing and selling drugs using unapproved API, according to the announcement.
, the legal representative of the company has organized the implementation of the above-mentioned illegal production and sales activities, and you shall be identified as the person in charge directly responsible in accordance with the law.
in accordance with the provisions of Article 75 of the Drug Administration Law of the People's Republic of China (as amended in 2015), it is proposed to impos administrative penalties on its legal persons for "not engaging in drug production or business activities for a 10-year term".
public information, the drug company used unapproved raw materials to illegally produce drugs and sell them, according to the requirements, its products should be punished according to the theory of counterfeit drugs.
under the Drug Administration Act (as amended in 2015), the use of RAW drugs that must obtain an approval number in accordance with this Act without obtaining an approval number shall be punished as counterfeit medicines.
new revision of the Drug Administration Act came into effect on 1 December 2019 and the penalties were in accordance with the 2015 version, as the time for the above-mentioned corporate offences was prior to the publication of the newly amended Drug Administration Act.
, what are the provisions for counterfeit drugs in the newly amended Drug Administration Act? According to the Drug Administration Law (as amended in 2019), counterfeit drugs are: (1) the contents of a drug do not conform to the contents stipulated in the national drug standard; (2) the impersonation of a drug with a non-drug or the impersonation of such a drug with another drug; (3) the treatment of a decuring drug; and (4) the main treatment of the drug exceeds the prescribed limits.
In addition, the Drug Administration Law stipulates that in one of the following cases, the content of the pharmaceutical ingredients does not meet the national drug standards; (2) the contaminated drugs; (3) the drugs that do not indicate or change the validity period; (4) the drugs that do not indicate or change the batch number of the product; (5) the drugs that exceed the validity period; (6) the drugs that do not meet the drug standards without authorization; (6) the drugs that do not meet the drug standards;
there are practicing pharmacists who have been sentenced for selling counterfeit drugs in the field of drug retailing, and there have also been cases in which practicing pharmacists have been fined for selling counterfeit drugs.
april this year, the Jiangsu Provincial Drug Administration issued a "notice on the criminal punishment of practicing pharmacists."
three practicing pharmacists were convicted of selling counterfeit drugs and criminally punished, according to a statement from the Court of Law.
, the local registration authority has cancelled its registration certificate in accordance with the provisions, the provincial bureau has entered its criminal punishment information into the national registration system of practicing pharmacists "reward and punishment record column."
addition, at the end of October last year, the Jiangsu Drug Administration also informed a "notice on the criminal punishment of practicing pharmacists", two practicing pharmacists were subject to criminal punishment.
, one practicing pharmacist was sentenced to six months' imprisonment, suspended for one year, with a fine of 2000 yuan, and another practicing pharmacist was sentenced to eight months' imprisonment, suspended for one year and fined 8,000 yuan.
and both were prohibited from engaging in related activities while on probation.
this shows that for practicing pharmacists, it is not only a simple job, not to review prescriptions, sell drugs on it, not to be able to simply register to earn extra money.
a practicing pharmacist with a very important responsibility.
The following penalties are imposed for the production and sale of counterfeit drugs under the Drug Administration Act (as amended in 2019): (Source: Drug Administration Act (as amended in 2019)) On the production and sale of counterfeit drugs, except in the Drug Administration Act Clear penalties, the Criminal Code also has clear penalties: (Source: Criminal Law) We can see that under the newly amended Drug Administration Act, the most severe penalty for the production and sale of counterfeit drugs is a lifetime ban on the production and operation of pharmaceuticals, more severe than the 10 years before the revision of the eviction from the industry.
and face more serious criminal penalties, such as jail time, in addition to a lifetime ban, if the sale of counterfeit drugs has serious consequences.
if you are a full-time practicing pharmacist at the drugstore involved, or a licensed licensed pharmacist, who happens to be a quality manager or a legal person, that would be a huge risk.
once a pharmacy owner sells counterfeit drugs in the store, the consequences are unimaginable.
In this way, although the current number of practicing pharmacists is still in short supply, the market demand is huge is also the industry consensus, but if the practicing pharmacists for the so-called additional income and choose to hang up, gambling is likely to be the future of their lives.
original title: There are medics, expelled from the industry for 10 years